» Articles » PMID: 31922250

How Galectins Have Become Multifunctional Proteins

Overview
Date 2020 Jan 11
PMID 31922250
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Having identified glycans of cellular glycoconjugates as versatile molecular messages, their recognition by sugar receptors (lectins) is a fundamental mechanism within the flow of biological information. This type of molecular interplay is increasingly revealed to be involved in a wide range of (patho)physiological processes. To do so, it is a vital prerequisite that a lectin (and its expression) can develop more than a single skill, that is the general ability to bind glycans. By studying the example of vertebrate galectins as a model, a total of five relevant characteristics is disclosed: i) access to intra- and extracellular sites, ii) fine-tuned gene regulation (with evidence for co-regulation of counterreceptors) including the existence of variants due to alternative splicing or single nucleotide polymorphisms, iii) specificity to distinct glycans from the glycome with different molecular meaning, iv) binding capacity also to peptide motifs at different sites on the protein and v) diversity of modular architecture. They combine to endow these lectins with the capacity to serve as multi-purpose tools. Underscoring the arising broad-scale significance of tissue lectins, their numbers in terms of known families and group members have steadily grown by respective research that therefore unveiled a well-stocked toolbox. The generation of a network of (ga)lectins by evolutionary diversification affords the opportunity for additive/synergistic or antagonistic interplay in situ, an emerging aspect of (ga)lectin functionality. It warrants close scrutiny. The realization of the enormous potential of combinatorial permutations using the five listed features gives further efforts to understand the rules of functional glycomics/lectinomics a clear direction.

Citing Articles

Cysteine Oxidation in Human Galectin-1 Occurs Sequentially via a Folded Intermediate to a Fully Oxidized Unfolded Form.

Ippel H, Miller M, Dings R, Ludwig A, Gabius H, Mayo K Int J Mol Sci. 2024; 25(13).

PMID: 39000066 PMC: 11241627. DOI: 10.3390/ijms25136956.


Biophysical and Structural Characterization of the Interaction between Human Galectin-3 and the Lipopolysaccharide from .

Pirone L, Pia Lenza M, Di Gaetano S, Capasso D, Filocaso M, Russo R Int J Mol Sci. 2024; 25(5).

PMID: 38474141 PMC: 10932368. DOI: 10.3390/ijms25052895.


Galectin-1 Modulates the Fusogenic Activity of Placental Endogenous Retroviral Envelopes.

Toudic C, Maurer M, St-Pierre G, Xiao Y, Bannert N, Lafond J Viruses. 2023; 15(12).

PMID: 38140682 PMC: 10747188. DOI: 10.3390/v15122441.


Heterologous Interactions with Galectins and Chemokines and Their Functional Consequences.

Mayo K Int J Mol Sci. 2023; 24(18).

PMID: 37762385 PMC: 10531749. DOI: 10.3390/ijms241814083.


Galectin-3 and Epithelial MUC1 Mucin-Interactions Supporting Cancer Development.

Radziejewska I Cancers (Basel). 2023; 15(10).

PMID: 37345016 PMC: 10216753. DOI: 10.3390/cancers15102680.


References
1.
Ackerman S, Corrette S, Rosenberg H, Bennett J, Mastrianni D, Nicholson-Weller A . Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol. 1993; 150(2):456-68. View

2.
Ahmad N, Gabius H, Andre S, Kaltner H, Sabesan S, Roy R . Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem. 2003; 279(12):10841-7. DOI: 10.1074/jbc.M312834200. View

3.
Akahani S, Nangia-Makker P, Inohara H, Kim H, Raz A . Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 1997; 57(23):5272-6. View

4.
Amano M, Eriksson H, Manning J, Detjen K, Andre S, Nishimura S . Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model. FEBS J. 2012; 279(21):4062-80. DOI: 10.1111/febs.12001. View

5.
Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K . Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and.... J Cancer Res Clin Oncol. 1999; 125(8-9):461-74. DOI: 10.1007/s004320050303. View